Click on the links below to read updates on the drug shortages. Or visit our drug shortage website to share your story.
Illustration courtesy of FDA.gov : http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm277626.htm
Take Action
Tell Congress How Ovarian Cancer Drug Shortages Are Affecting You
Sign our petition to end drug shortages
Gray Market Tipline
From the Ovarian Cancer National Alliance
Letter to House re: Drug Shortages June 2012
Letter to Senate re: Drug Shortages June 2012
Alliance comments to Senate on drug shortages bill
Press release: Patient Advocates Encouraged That Ovarian Cancer Trial Will Advance, Thanks to FDA Approval to Re-Import Doxil®
Watch Drug Shortages: Status and Next Steps webinar
August 24 statement
September 27 update
Letter to Representative DeGette (D-CO)
Letter to Senator Klobuchar (D-MN)
Statement on Executive Order from the White House
Congressional Action
Letter to Congress about Gray Market Drug Sales
Congressional Report on FDA’s Contribution to the Drug Shortage Crisis
News
Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages
Quality issues at factories contribute to shortages
FDA and industry not waiting for Congress on drug shortages
Manufacturers, market have role in drug shortages
White House Press Release
Drug Shortages hit pharmacies in Canada and the US
Chemotherapy Drug Shortages Include Taxol
US Scrambling to Ease Shortage of Vital Medicine
Cancer Drug Shortages Getting Worse, FDA Says
Shortages Lead Doctors to Ration Drugs
Congressman probes shortages, price mark ups
Authorities Perplexed by Spike in Shortages
Editorial: A shortage of drugs in a free market?
Drug shortage puts patients at risk in Vermont
Doctors: Shortage of cheap cancer medicines is obscene
NYTimes: Obama Tries to Speed Response to Shortages in Vital Medicine
The Shortage of Essential Chemotherapy Drugs in the United States
A free-market solution for drug shortages
Drug Shortages – A Critical Challenge for the Generic Drug Market
Outside Resources
Helpful links about the Doxil shortage from the American Society of Clinical Oncology
